补肾益气汤辅助治疗肺源性心脏病缓解期患者的效果及安全性评价
古锦田 1 , 李 轲 2 , 杨小庆 1
(1.唐河县中医院内科七病区,河南 唐河 473400;2.南阳市中医院肾病科,河南 南阳 473000)
摘要 目的:研究补肾益气汤辅助治疗肺源性心脏病缓解期患者的效果及安全性。 方法:选取肺源性心脏病缓解期患者 106 例,依照治疗方案不同分为常规组和研究组,每组各 53 例。 常规组予以常规西医治疗,研究组予以中西医结合治疗。 对比两组疗效、治疗前后肺功能指标[用力肺活量(FVC)、第 1 秒用力呼气容积(FEV 1 )、FEV 1 占预计值百分比(FEV 1 %)]、心功能指标[肺动脉收缩压(PASP)、右心室每搏量(RVSV)、右心室舒张末期容积(RVEDV)、右心室射血分数(RVEF)]、脑纳肽(BNP)浓度、生活质量。 结果:研究组总有效率 96.23%(51/53)高于常规组 75.47%(40/53),两组比较差异有统计学意义(P<0.05);研究组 FEV 1 、FVC、FEV 1 %均高于常规组,两组比较差异有统计学意义(P<0.05);治疗后,研究组 PASP、RVEDV、BNP 浓度低于常规组,RVSV、RVEF 高于常规组,两组比较差异有统计学意义(P<0.05);治疗后,研究组活动受限评分、症状评分、SGRQ 总分、疾病影响评分均低于常规组,两组比较差异有统计学意义(P<0.05)。 结论:补肾益气汤辅助治疗肺源性心脏病缓解期效果显著,能提升患者肺功能、心功能,有助于提高生活质量。
关键词: 补肾益气汤;常规西医治疗;肺源性心脏病缓解期
中图分类号:R541.5 文献标志码:A 文章编号:1008-2409(2022)03-0111-05
Efficacy and safety of Bushen Yiqi decoction in adjuvant treatment of patients with cor pulmonale in remission
GU Jintian 1 , LI Ke 2 , YANG Xiaoqing 1 . (1. Ward VII of Department of Internal Medicine, Hospital of Traditional Chinese Medicine of Tanghe County, Tanghe 473400, China; 2. Dept. of Nephrology, Nanyang Hospital of Traditional Chinese Medicine, Nanyang 473000, China)
Abstract Objective: To study the efficacy and safety of Bushen Yiqi decoction in adjuvant treatment of patients with cor pulmonale in remission. Methods: A total of 106 patients with cor pulmonale in remission were selected and randomized into a conventional group and an experimental group according to different treatment regimens, with 53 cases in each group. The conventional group were treated with conventional Western medicine, while the experimental group were treated with integrated traditional Chinese and Western medicine. Then, the efficacy, the pulmonary function indexes[forced vital capacity(FVC), forced expiratory volume in the first second ( FEV1), percentage of FEV1 to the predicted value (FEV1%)], heart function indexes[pulmonary artery systolic pressure(PASP), right ventricular stroke volume(RVSV), right ventricular end-diastolic volume (RVEDV), right ventricular ejection fraction (RVEF)], brain napeptide(BNP) concentration, and quality of life before and after treatments were compared between the two groups, 75.47%(40/53). Results: The total effective rate of the experimental group was 96.23%(51/53), higher than 75.47%(40/53) of the conventional group, and the difference was statistically significant (P < 0. 05); FEV1, FVC and FEV1% were all higher than those of the conventional group, with statistical differences(P<0.05); after treatment, the concentrations of PASP, RVEDV and BNP in the experimental group were lower than those in the conventional group, and RVSV and RVEF were higher than those in the conventional group, the differences were statistically significant(P<0.05); the activity restriction score, symptom score, SGRQ total score, and disease impact score of the experimental group were lower than those of the conventional group, which were of statistical significances (P<0.05). Conclusion: Bushen Yiqi decoction has a significant effect in the adjuvant treatment of patients with cor pulmonale in the remission, which can improve the lung function and heart function and help improve the quality of life of patients.
Keywords: Bushen Yiqi decoction; conventional western medicine treatment; pulmonary heart disease in remission
参考文献:
[1] 赵珊珊,秦芳,李静.前列地尔治疗慢性肺源性心脏病肺动脉高压患者的 Meta 分析[J]. 临床药物治疗杂志,2019,17(1):60-65.
[2] 高杨,李杰,王增智,等.支气管扩张症合并慢性肺源性心脏病临床特点分析[J].心肺血管病杂志,2019,38(1):26-29,39.
[3] 刘艳强.益心舒胶囊联合地高辛治疗慢性肺源性心脏病的临床疗效研究[J].中国药物与临床,2020,20(21):3595-3597.
[4] 杨媛华.慢性肺源性心脏病的识别与诊断[J].中华全科医师杂志,2019,18(9):900-901.
[5] 李晓宇,王振亮,张文,等.从“随脏腑之性而治”探讨慢性肺源性心脏病[J].中华中医药杂志,2019,34(3):1080-1083.
[6] 李同林,刘蔺,周航.慢性肺源性心脏病急性加重患者在常规治疗基础上加用左卡尼丁对血浆 B 型钠尿肽及心肺功能、血气状况、血流动力学、凝血功能指标的影响[J].陕西医学杂志,2019,48(1):96-98,124.
[7] 杨静,马泉,张元.益气温阳活血利水法对慢性肺源性心脏病大鼠水通道蛋白 4 表达的影响及机制研究[J].中国免疫学杂志,2019,35(21):2599-2603.
[8] 胡晓玲,安静,吴海斌,等.基于心肺同治理论应用益气化痰活血方治疗慢性肺源性心脏病合并冠心病气虚痰瘀互结证的临床观察[J].中华中医药杂志,2019,34(7):3323-3326.
[9] 陈晶晶,刘玲,董梅,等.蛤蚧治疗肺病研究进展[J].中医学报,2019,34(8):1634-1637.
[10] 谢东.中医益气补肾化痰祛瘀法对缓解期慢性阻塞性肺疾病并肺源性心脏病患者生存质量的影响[J].现代中西医结合杂志,2019,28(12):1329-1331.
[11] 李红丽,文丹丹,周美亮,等.金荞麦抑瘤活性成份提取及作用机制研究进展[J].中国临床药理学与治疗学,2019,24(7):833-840.
[12] 束沛,郑忻,席瑞,等.柴胡-黄芩药对防治新型冠状病毒肺炎网络药理学分子机制研究[J].辽宁中医药大学学报,2021,23(1):94-99.
[13] 周亮,高华新.慢性肺源性心脏病患者血清 BNP、TNI 和D-Dimer 水平及意义[J].湖南师范大学学报(医学版),2020,17(4):173-175.
PDF下载：点击下载
版权所有：华夏医学(Acta Medicinae Sinica) 联系电话：0773-2805467 电子邮箱：huaxia@glmc.edu.cn 地址：广西桂林市临桂区致远路1号桂林医学院明德楼316 (541199)